Lithium Resistance in Bipolar Tied to Deficient Gene Expression
A decrease in activation of the LEF1 gene may be the reason why many patients with bipolar disorder do not respond to lithium, considered the 'gold standard' treatment, new research suggests. Medscape Medical News
Source link